158 related articles for article (PubMed ID: 22682301)
1. Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent.
Mun J; Jabbar AA; Devi NS; Liu Y; Van Meir EG; Goodman MM
Bioorg Med Chem; 2012 Jul; 20(14):4590-7. PubMed ID: 22682301
[TBL] [Abstract][Full Text] [Related]
2. Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.
Mun J; Jabbar AA; Devi NS; Yin S; Wang Y; Tan C; Culver D; Snyder JP; Van Meir EG; Goodman MM
J Med Chem; 2012 Aug; 55(15):6738-50. PubMed ID: 22746274
[TBL] [Abstract][Full Text] [Related]
3. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract][Full Text] [Related]
4. KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology.
Wang W; Ao L; Rayburn ER; Xu H; Zhang X; Zhang X; Nag SA; Wu X; Wang MH; Wang H; Van Meir EG; Zhang R
PLoS One; 2012; 7(9):e44883. PubMed ID: 23028659
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.
Mooring SR; Jin H; Devi NS; Jabbar AA; Kaluz S; Liu Y; Van Meir EG; Wang B
J Med Chem; 2011 Dec; 54(24):8471-89. PubMed ID: 22032632
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
Yasuda Y; Arakawa T; Nawata Y; Shimada S; Oishi S; Fujii N; Nishimura S; Hattori A; Kakeya H
Bioorg Med Chem; 2015 Apr; 23(8):1776-87. PubMed ID: 25773014
[TBL] [Abstract][Full Text] [Related]
7. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents.
Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A
Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485
[TBL] [Abstract][Full Text] [Related]
8. Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation.
Van Luu C; Van Chau M; Lee JJ; Jung SH
Arch Pharm Res; 2006 Oct; 29(10):840-4. PubMed ID: 17121177
[TBL] [Abstract][Full Text] [Related]
9. Diversity-oriented generation and biological evaluation of new chemical scaffolds bearing a 2,2-dimethyl-2H-chromene unit: Discovery of novel potent ANO1 inhibitors.
Seo Y; Choi J; Lee JH; Kim TG; Park SH; Han G; Namkung W; Kim I
Bioorg Chem; 2020 Aug; 101():104000. PubMed ID: 32592976
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines.
Musa MA; Badisa VL; Latinwo LM; Cooperwood J; Sinclair A; Abdullah A
Anticancer Res; 2011 Jun; 31(6):2017-22. PubMed ID: 21737617
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility.
Ferguson JH; De Los Santos Z; Devi SN; Kaluz S; Van Meir EG; Zingales SK; Wang B
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):992-1001. PubMed ID: 28766956
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential.
Wei J; Yang Y; Li Y; Mo X; Guo X; Zhang X; Xu X; Jiang Z; You Q
Bioorg Med Chem; 2017 Mar; 25(6):1737-1746. PubMed ID: 28209257
[TBL] [Abstract][Full Text] [Related]
13. Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors.
Tan C; de Noronha RG; Devi NS; Jabbar AA; Kaluz S; Liu Y; Mooring SR; Nicolaou KC; Wang B; Van Meir EG
Bioorg Med Chem Lett; 2011 Sep; 21(18):5528-32. PubMed ID: 21831638
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Molecules Composed of 2,4-Diamino-1,3,5-triazines and 2-Imino-Coumarins and Coumarins. Synthesis and Cytotoxic Properties.
Makowska A; Sączewski F; Bednarski PJ; Sączewski J; Balewski Ł
Molecules; 2018 Jul; 23(7):. PubMed ID: 29970833
[TBL] [Abstract][Full Text] [Related]
15. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
16. Benzochromenones from the marine crinoid Comantheria rotula inhibit hypoxia-inducible factor-1 (HIF-1) in cell-based reporter assays and differentially suppress the growth of certain tumor cell lines.
Dai J; Liu Y; Jia H; Zhou YD; Nagle DG
J Nat Prod; 2007 Sep; 70(9):1462-6. PubMed ID: 17844994
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors.
Li G; Dong H; Ma Y; Shao K; Li Y; Wu X; Wang S; Shao Y; Zhao W
Bioorg Med Chem Lett; 2019 Aug; 29(16):2327-2331. PubMed ID: 31281016
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic evaluation of benzoxazole/benzothiazole-2-imino-coumarin hybrids and their coumarin analogues as potential anticancer agents.
Makowska A; Wolff L; Sączewski F; Bednarski PJ; Kornicka A
Pharmazie; 2019 Nov; 74(11):648-657. PubMed ID: 31739830
[TBL] [Abstract][Full Text] [Related]
19. Chromenes of polyketide origin from Peperomia villipetiola.
Malquichagua Salazar KJ; Delgado Paredes GE; Lluncor LR; Young MC; Kato MJ
Phytochemistry; 2005 Mar; 66(5):573-9. PubMed ID: 15721950
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity.
Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2011 Apr; 21(8):2341-4. PubMed ID: 21420855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
